These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35871018)

  • 41. Intellectual functioning in alpha-mannosidosis.
    Cathey SS; Sarasua SM; Simensen R; Pietris K; Kimbrell G; Sillence D; Wilson C; Horowitz L
    JIMD Rep; 2019 Nov; 50(1):44-49. PubMed ID: 31741826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioural characterisation of the alpha-mannosidosis guinea pig.
    Robinson AJ; Crawley AC; Auclair D; Weston PF; Hirte C; Hemsley KM; Hopwood JJ
    Behav Brain Res; 2008 Jan; 186(2):176-84. PubMed ID: 17889945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha-mannosidosis in Tunisian consanguineous families: Potential involvement of variants in GHR and SLC19A3 genes in the variable expressivity of cognitive impairment.
    Mkaouar R; Riahi Z; Charfeddine C; Chelly I; Boudabbous H; Dallali H; Bonnet C; Hechmi M; Bekri S; Zitouna N; Zekri L; Tounsi A; Kefi R; Marrakchi J; Messaoud O; Kraoua I; Maalej S; Turki Ben Youssef I; Ben Hmid A; Giraudet F; Bouchoucha S; Tebib N; Besbes G; Petit C; Mrad R; Abdelhak S; Trabelsi M
    PLoS One; 2021; 16(10):e0258202. PubMed ID: 34614013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation.
    Grewal SS; Shapiro EG; Krivit W; Charnas L; Lockman LA; Delaney KA; Davies SM; Wenger DA; Rimell FL; Abel S; Grovas AC; Orchard PJ; Wagner JE; Peters C
    J Pediatr; 2004 May; 144(5):569-73. PubMed ID: 15126988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe periodontal destruction in alpha-mannosidosis: a case series.
    Kalsi JS; Auplish G; Johnson AR; Darbar UR
    Pediatr Dent; 2012; 34(5):140-3. PubMed ID: 23211899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mannosidosis type II].
    Tranchant C; Reis J; Dietemann JL; Lannes B; Maire I; Warter JM
    Rev Neurol (Paris); 1991; 147(5):364-7. PubMed ID: 1853034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychiatric symptoms in alpha-mannosidosis.
    Malm D; Pantel J; Linaker OM
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):865-71. PubMed ID: 16207285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical and pathologic heterogeneity of feline alpha-mannosidosis.
    Cummings JF; Wood PA; de Lahunta A; Walkley SU; Le Boeuf L
    J Vet Intern Med; 1988; 2(4):163-70. PubMed ID: 3230555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pediatric audiologic-phoniatric aspects of mannosidosis].
    Kraft E; Zorowka P
    HNO; 1990 Mar; 38(3):99-101. PubMed ID: 2341299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. alpha-Mannosidosis: functional cloning of the lysosomal alpha-mannosidase cDNA and identification of a mutation in two affected siblings.
    Nilssen O; Berg T; Riise HM; Ramachandran U; Evjen G; Hansen GM; Malm D; Tranebjaerg L; Tollersrud OK
    Hum Mol Genet; 1997 May; 6(5):717-26. PubMed ID: 9158146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcome of patients with alpha-mannosidosis - A single center study.
    Lipiński P; Różdżyńska-Świątkowska A; Iwanicka-Pronicka K; Perkowska B; Pokora P; Tylki-Szymańska A
    Mol Genet Metab Rep; 2022 Mar; 30():100826. PubMed ID: 35242565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term enzyme replacement therapy improves neurocognitive functioning and hippocampal synaptic plasticity in immune-tolerant alpha-mannosidosis mice.
    Stroobants S; Damme M; Van der Jeugd A; Vermaercke B; Andersson C; Fogh J; Saftig P; Blanz J; D'Hooge R
    Neurobiol Dis; 2017 Oct; 106():255-268. PubMed ID: 28720484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow transplantation in the treatment of alpha-mannosidosis.
    Will A; Cooper A; Hatton C; Sardharwalla IB; Evans DI; Stevens RF
    Arch Dis Child; 1987 Oct; 62(10):1044-9. PubMed ID: 3314721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal transplantation in a case of mannosidosis.
    Segoloni GP; Colla L; Messina M; Stratta P
    Transplantation; 1996 Jun; 61(11):1654-5. PubMed ID: 8669114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha-mannosidosis: a report of 2 siblings and review of the literature.
    Govender R; Mubaiwa L
    J Child Neurol; 2014 Jan; 29(1):131-4. PubMed ID: 23307885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human beta-mannosidosis: a 3-year-old boy with speech impairment and emotional instability.
    Poenaru L; Akli S; Rocchiccioli F; Eydoux P; Zamet P
    Clin Genet; 1992 Jun; 41(6):331-4. PubMed ID: 1623631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mannosidosis in Galloway calves.
    Embury DH; Jerrett IV
    Vet Pathol; 1985 Nov; 22(6):548-51. PubMed ID: 4082380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Funtional characterization of four novel MAN2B1 mutations causing juvenile onset alpha-mannosidosis.
    Pittis MG; Montalvo AL; Heikinheimo P; Sbaragli M; Balducci C; Persichetti E; Van Maldergem L; Filocamo M; Bembi B; Beccari T
    Clin Chim Acta; 2007 Jan; 375(1-2):136-9. PubMed ID: 16919251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral zinc therapy in the treatment of alpha-mannosidosis.
    Wong LT; Vallance H; Savage A; Davidson AG; Applegarth D
    Am J Med Genet; 1993 Jun; 46(4):410-4. PubMed ID: 8357013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.
    Damme M; Stroobants S; Walkley SU; Lüllmann-Rauch R; D'Hooge R; Fogh J; Saftig P; Lübke T; Blanz J
    J Neuropathol Exp Neurol; 2011 Jan; 70(1):83-94. PubMed ID: 21157375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.